Anvis Laboratories
+91 22 2830 2279

Anvis Laboratories Pvt. Ltd.

2/A-5, Priyadarshini, Poonam Nagar, Off Mahakali Road, Andheri East, Mumbai – 400 093, India

info@anvis-labratories.com

Anvis Laboratories
+91 22 2830 2279

Anvis Laboratories Pvt. Ltd.

2/A-5, Priyadarshini, Poonam Nagar, Off Mahakali Road, Andheri East, Mumbai – 400 093, India

info@anvis-labratories.com

Products Details

Redefining care through innovation. ANVIS empowers a healthier tomorrow with every solution we provide.
Anvis Labratories
Trusted Medicines, Better Lives

Vipival 500

Vipival 500 by ANVIS is labelled divalproex sodium 500 mg, equivalent to valproic acid. Pack presentation: 3 × 10 tablets. Specialist guidance and safety monitoring are essential.

Info Product

Description

Vipival 500 is an ANVIS tablet product. Its carton states divalproex sodium 500 mg. The photographed presentation contains 3 × 10 tablets (30 tablets). This catalogue entry records the visible packaging details and provides general ingredient information.

Vipival 500 product specification

  • Product name: Vipival 500
  • Ingredient: Divalproex sodium
  • Labelled strength: 500 mg
  • Dosage form: Tablets
  • Pack presentation: 3 × 10 tablets (30 tablets)
  • Brand: ANVIS

First, match the full product name, dosage form and packaging to the item supplied. However, the number of tablets describes the carton contents. It does not establish a daily dose or the length of treatment. Therefore, check other strengths and formulations separately.

General information about divalproex sodium

The body converts divalproex sodium to valproic acid. Clinicians use valproate medicines for certain seizure disorders and other selected conditions. The condition, formulation and individual risks determine the treatment plan. Therefore, do not switch release formulations without professional advice.

Vipival 500: important safety warnings

Valproate can cause serious birth defects and developmental harm during pregnancy. Discuss suitable alternatives and pregnancy-prevention requirements with a specialist. In addition, if pregnancy occurs during treatment, contact the prescriber immediately. However, do not stop treatment suddenly without medical guidance.

Serious liver and pancreas injury can occur. Seek prompt medical attention for yellow skin or eyes, dark urine, marked unusual tiredness, persistent severe abdominal pain or repeated vomiting. Also keep monitoring appointments and tell your clinician about other medicines. Read the full supplied leaflet before treatment.

Documentation and product enquiries

The MedlinePlus valproic acid guide provides general ingredient information. It is not a substitute for the leaflet supplied with this exact product. For complete Vipival 500 documentation or availability, contact ANVIS and quote the name and pack presentation. You can also browse our tablet catalogue.

Reviews

There are no reviews yet.

Be the first to review “Vipival 500”

Your email address will not be published. Required fields are marked *